What is the address of GYN-OBST?

The registered office of GYN-OBST is located at François Ruytinxstraat 9, 1170 Watermaal-Bosvoorde.

Is GYN-OBST still active?

Yes. According to the CBE (19 September 2026) GYN-OBST is active, legal situation “Normale toestand”, started on 17 July 2008.

Is GYN-OBST registered on Peppol?

Yes, GYN-OBST is registered on the Peppol network with ID 0208:0899357868.

What is the enterprise number of GYN-OBST?

The enterprise number of GYN-OBST is BE0899357868.

When was GYN-OBST founded?

GYN-OBST was founded on 17 July 2008.

Who are the directors of GYN-OBST?

According to the 2025 annual accounts, the directors of GYN-OBST are: JEAN-FREDERIC LIMBOSCH.

Is GYN-OBST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 July 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GYN-OBST make in 2025?

GYN-OBST posted a profit after taxes of € 235,024 in financial year 2025.

What is the revenue of GYN-OBST?

As a small company, GYN-OBST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 294,399.

Does GYN-OBST have a website?

Yes, GYN-OBST has a website at gyneco-limbosch.be.

GYN-OBST (Private Limited) - Watermaal-Bosvoorde

Dossier GYN-OBST, printed on 19 September 2026 from databakkes.be/en/0899357868/gyn-obst. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

GYN-OBST from Watermaal-Bosvoorde, company number BE0899357868, closed financial year 2025 with a result of € 235,024 after tax. For that financial year GYN-OBST recorded a gross margin of € 294,399 and equity of € 387,694. Compared with financial year 2024, the result moved from € 184,892 to € 235,024. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 11, 2025.

What it is worth Healthy

€ 387,694

▼ 43% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 235,024

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 115,406

▼ 79% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 531,525 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 8,357

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 15,312

▼ 20% vs 2024

€ 3,800 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 841

▼ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 73,850

▲ 72% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 211,171 Gross margin 2022: € 211,171 First fiscal year in the series	€ 250,155 Gross margin 2023: € 250,155 ▲ 18% vs 2022 (€ 211,171) Favourable step	€ 248,644 Gross margin 2024: € 248,644 ▼ 1% vs 2023 (€ 250,155) Unfavourable step	€ 294,399 Gross margin 2025: € 294,399 ▲ 18% vs 2024 (€ 248,644) Favourable step	▲ 18%
Profit after taxes	€ 118,633 Profit after taxes 2022: € 118,633 First fiscal year in the series	€ 184,839 Profit after taxes 2023: € 184,839 ▲ 56% vs 2022 (€ 118,633) Favourable step	€ 184,892 Profit after taxes 2024: € 184,892 Unchanged (€ 184,839) Favourable step	€ 235,024 Profit after taxes 2025: € 235,024 ▲ 27% vs 2024 (€ 184,892) Favourable step	▲ 27%
Equity	€ 773,195 Equity 2022: € 773,195 First fiscal year in the series	€ 684,195 Equity 2023: € 684,195 ▼ 12% vs 2022 (€ 773,195) Unfavourable step	€ 684,195 Equity 2024: € 684,195 Unchanged (€ 684,195) Unchanged	€ 387,694 Equity 2025: € 387,694 ▼ 43% vs 2024 (€ 684,195) Unfavourable step	▼ 43%
Total debts	€ 172,252 Total debts 2022: € 172,252 First fiscal year in the series	€ 301,557 Total debts 2023: € 301,557 ▲ 75% vs 2022 (€ 172,252) Unfavourable step	€ 299,342 Total debts 2024: € 299,342 ▼ 1% vs 2023 (€ 301,557) Favourable step	€ 562,484 Total debts 2025: € 562,484 ▲ 88% vs 2024 (€ 299,342) Unfavourable step	▲ 88%
Cash	€ 759,815 Cash 2022: € 759,815 First fiscal year in the series	€ 819,449 Cash 2023: € 819,449 ▲ 8% vs 2022 (€ 759,815) Favourable step	€ 537,580 Cash 2024: € 537,580 ▼ 34% vs 2023 (€ 819,449) Unfavourable step	€ 115,406 Cash 2025: € 115,406 ▼ 79% vs 2024 (€ 537,580) Unfavourable step	▼ 79%
Retained profit	€ 680,195 Retained profit 2022: € 680,195 First fiscal year in the series	€ 591,195 Retained profit 2023: € 591,195 ▼ 13% vs 2022 (€ 680,195) Unfavourable step	€ 591,195 Retained profit 2024: € 591,195 Unchanged (€ 591,195) Unchanged	€ 294,694 Retained profit 2025: € 294,694 ▼ 50% vs 2024 (€ 591,195) Unfavourable step	▼ 50%
Dividend	€ 108,460 Dividend 2022: € 108,460 First fiscal year in the series	€ 273,839 Dividend 2023: € 273,839 ▲ 152% vs 2022 (€ 108,460) Unchanged	€ 184,892 Dividend 2024: € 184,892 ▼ 32% vs 2023 (€ 273,839) Unchanged	€ 531,525 Dividend 2025: € 531,525 ▲ 187% vs 2024 (€ 184,892) Unchanged	▲ 187%
Bank debt	€ 26,495 Bank debt 2022: € 26,495 First fiscal year in the series	€ 22,835 Bank debt 2023: € 22,835 ▼ 14% vs 2022 (€ 26,495) Favourable step	€ 19,112 Bank debt 2024: € 19,112 ▼ 16% vs 2023 (€ 22,835) Favourable step	€ 15,312 Bank debt 2025: € 15,312 ▼ 20% vs 2024 (€ 19,112) Favourable step	▼ 20%
Balance sheet total	€ 963,807 Balance sheet total 2022: € 963,807 First fiscal year in the series	€ 1,004,112 Balance sheet total 2023: € 1,004,112 ▲ 4% vs 2022 (€ 963,807) Unchanged	€ 1,001,897 Balance sheet total 2024: € 1,001,897 Unchanged (€ 1,004,112) Unchanged	€ 968,538 Balance sheet total 2025: € 968,538 ▼ 3% vs 2024 (€ 1,001,897) Unchanged	▼ 3%

Key figures of GYN-OBST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to GYN-OBST?

What happened at GYN-OBST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 11, 2025 New annual accounts for financial year 2025: profit of € 235,024 (▲ 27% vs 2024). Source: NBB ↗
Jul 17, 2008 New establishment in Elsene. KBO
Jul 17, 2008 Start of the company according to the CBE. KBO

In short

From € 118,633 profit in 2022 to € 235,024 profit in 2025.

Paid € 252,903 in corporate taxes since 2022.

Best year ever: 2025, with € 235,024 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GYN-OBST? We notify you, reason included.

Follow GYN-OBST

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JEAN-FREDERIC LIMBOSCH

GYN-OBST

Behind GYN-OBST is JEAN-FREDERIC LIMBOSCH.

See the full network in the app

Directors

According to the 2025 annual accounts

JEAN-FREDERIC LIMBOSCH

Director

Establishments

Establishment units

Physical locations of this company

Registered office

François Ruytinxstraat 9

1170 Watermaal-Bosvoorde

2.387.769.321

Latijnensquare 9

1050 Elsene

Active since 17 July 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP gyneco-limbosch.be

Technologies

DrupalGoogle AnalyticsPHPjQuery

Hosting & Email

Email provider

Google Workspace

Hosting

OVH, FR

DNS

OVH DNS

Website info

HTTPS Nee

Languages FR

Features

Security

✗ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0899.357.868
VAT number: BE 0899.357.868
Registered office: François Ruytinxstraat 9, 1170 Watermaal-Bosvoorde
Names & denominations: GYN-OBST
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 July 2008
Peppol: Active · Active since 9 Feb 2026
Contact: gyneco-limbosch.be

View on CBE Public ↗ Annual accounts (NBB) ↗